Search
Patients & Visitors For Professionals LEAN Academy

Nationally Ranked Locally Trusted | (303) 436-6000

 
You are using an unlicensed and unsupported version of DotNetNuke Professional Edition. Please contact sales@dnncorp.com for information on how to obtain a valid license.

Diabetes Insipidus

Pronounced: diabetes -in-' sip-d-s

Definition

Diabetes insipidus is a condition where water in the body is improperly removed from the circulatory system by the kidneys.

There are two forms of diabetes insipidus (DI):

  • Central diabetes insipidus (central DI)
  • Nephrogenic diabetes insipidus (NDI)

Causes    TOP

Antidiuretic hormone (ADH) controls the amount of water reabsorbed by the kidneys. ADH is made in the hypothalamus of the brain. The pituitary gland, at the base of the brain, stores and releases ADH.

Central DI occurs when the hypothalamus does not make enough ADH.

NDI occurs when the kidneys do not respond to ADH.

Some diabetes insipidus is casued by genetic problems that lead to central DI or NDI. Others may develop after an injury or illness.

Pituitary Gland

Nucleus factsheet image
Copyright © Nucleus Medical Media, Inc.

Risk Factors    TOP

Factors that may increase your risk of diabetes insipidus include:

  • Damage to the hypothalamus or pituitary glands due to surgery, infection, stroke, tumor, or head injury
  • Certain conditions (such as sarcoidosis, tuberculosis, granulomatosis with polyangiitis)
  • Certain medicines (such as lithium)—the most common cause of diabetes insipidus
  • Kidney disease (such as polycystic kidney disease)
  • Protein malnutrition
  • Certain conditions (such as hypercalcemia, hypokalemia)

Symptoms    TOP

Symptoms may include:

  • Increased urination, especially during the night
  • Extreme thirst
  • Dehydration (fast heart rate, dry skin and mouth)

Diagnosis    TOP

Your doctor will ask about your symptoms and medical history. A physical exam may be done.

Tests may include the following:

  • Blood tests
    • Electrolyte levels
    • Kidney function tests
    • ADH levels
    • Blood sugar to look for diabetes mellitus
  • Urinalysis
    • Urine specific gravity and/or osmolality (measures how concentrated or dilute the urine is)
    • Urine volume tests to see how much urine is being produced
  • Water deprivation test
    • Only done under doctor supervision
    • Urine output is measured for a 24-hour period
  • Magnetic resonance imaging (MRI) of the head—if central CDI is suspected

Treatment    TOP

Talk with your doctor about the best plan for you. Your doctor will work with you to address the underlying cause.

Treatment may include:

  • For central DI—taking a synthetic form of ADH
  • For NDI—following a low-sodium diet, drinking plenty of water, taking a diuretic (water pill)

Prevention    TOP

There are no known ways to prevent diabetes insipidus. Talk to the doctor right away if you have excessive urination or thirst.

RESOURCES:

American Diabetes Association
http://www.diabetes.org/
Nephrogenic Diabetes Insipidus Foundation
http://www.ndif.org/

CANADIAN RESOURCES:

Canadian Diabetes Association
http://www.diabetes.ca

References:

Central diabetes insipidus. EBSCO DynaMed website. Available at: http://dynamed.ebscohost.com/about/about-us . Updated September 1, 2011. Accessed July 31, 2012.
Garofeanu CG, Weir M, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis . 2005;45:626-637.
Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev . 2006;Suppl 1:60-65.
Nephrogenic diabetes insipidus. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated September 1, 2011. Accessed July 31, 2012.
Patient information publications: diabetes insipidus. NH Clinical Center website. Available at: http://www.cc.nih.gov/ccc/patient_education/pepubs/di.pdf . Published 2006. Accessed July 31, 2012.
Rivkees SA, Dunbar N, et al. The management of central diabetes insipidus in infancy: desmopressin, low renal solue load formula, thazide diuretics. J Pediatr Endocrinol Metab . 2007;20:459-469.
Sands JM, Bichet DG. Nephogenic diabetes insipidus. Annals Int Med . 2006;144:186-194.
Toumba M, Stanhope R. Morbidity and mortality associated with vasopressin analogue treatment. Pediatr Endocrinol Metab . 2006;19:197-201.
Last reviewed September 2013 by Kim Carmichael, MD
Last Updated: 9/30/2013